Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04374773 · ClinicalTrials.gov registry record · Phase 4
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
A Phase 4 study of Pregnancy Related and Cannabis Use, sponsored by University of Washington.
- Active
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT04374773 is a Phase 4 study of Pregnancy Related and Cannabis Use that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 12 participants, below the 1,963-participant average among 99 other Pregnancy Related trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04374773, a Phase 4 study of Pregnancy Related and Cannabis Use, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Cannabis use is prevalent among pregnant women, but the effects of use on both the developing fetus and pregnant woman are unknown. Importantly, drug exposure could be influenced by the impact of pregnancy-associated hormones on the metabolism of tetrahydrocannabinol (THC), the main psychoactive component of cannabis. The goal of this study is to determine whether cortisol and estradiol - hormones that rise dramatically during pregnancy - increase the clearance of dronabinol (THC) in reproductive age women to simulate the pregnant state. The collected data will then be used to predict the time course and magnitude of changes in THC metabolism in pregnant women, particularly with gradually increasing estradiol and cortisol concentrations that evolve over the course of pregnancy. The overall objective of this study is to better understand the effects of THC use during pregnancy on the health of the pregnant woman and developing fetus.
Conditions Studied
Interventions
- DRUG Dronabinol
Study Locations (1)
Washington
- Nina Isoherranen - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-10-19 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04374773
The ClinicalTrials.gov registry entry for NCT04374773 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,963-participant average among 99 other Pregnancy Related trials with a reported enrollment target (99% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Dronabinol is the first listed.
NCT04374773 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT04374773 about?
NCT04374773 is a clinical study titled "Effects of Pregnancy-associated Hormones on THC Metabolism in Women". Cannabis use is prevalent among pregnant women, but the effects of use on both the developing fetus and pregnant woman are unknown. Importantly, drug exposure could be influenced by the impact of pregnancy-associated hormones on the metabolism of tetrahydrocannabinol (THC), the main psychoactive com...
What is the current status of trial NCT04374773?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2020-10-19. Estimated completion is 2025-12-31.
What conditions does trial NCT04374773 study?
This clinical trial studies the following conditions: Pregnancy Related, Cannabis Use.
What interventions are being tested in trial NCT04374773?
The interventions under investigation include: Dronabinol (DRUG).
Who is sponsoring clinical trial NCT04374773?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04374773 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
RECRUITING · Phase 4
-
Perineal Massage Using A Pelvic Wand During Pregnancy
RECRUITING · Phase 4
-
Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients
ACTIVE NOT RECRUITING · Phase 4
-
Misoprostol Dosing in BMI Greater Than 30
COMPLETED · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.